Urine Markers May Aid Psych Diagnosis
Genetically predicted urinary metabolite levels were associated with schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder, and anorexia nervosa in a Mendelian randomization analysis.
By
Andrea Surnit
May 15, 2026
Clinical Scorecard: Urine Markers May Aid Psych Diagnosis
At a Glance
Category Detail
Condition Psychiatric Disorders Key Mechanisms Genetically predicted associations between urinary metabolites and psychiatric disorders. Target Population Patients with psychiatric disorders, primarily of European ancestry. Care Setting Research and potential clinical application following validation.
Key Highlights
Identified 67 metabolite-disorder associations involving 44 unique analytes. Robust inverse association between urinary tyrosine levels and schizophrenia risk. Overlap in metabolite associations between bipolar disorder and schizophrenia. No significant associations found for autism spectrum condition, major depressive disorder, or Tourette syndrome. Findings require further validation before clinical application. Guideline-Based Recommendations
Diagnosis
Further validation of urinary biomarkers is necessary before clinical use. Management
Consider potential urinary metabolite biomarkers for differential diagnosis. Monitoring & Follow-up
Monitor urinary analyte levels, keeping in mind variability due to hydration, diet, and activity. Risks
Potential misdiagnosis between bipolar disorder and schizophrenia due to overlapping metabolite associations. Patient & Prescribing Data
Patients with psychiatric disorders, primarily of European ancestry.
Urinary metabolite levels may inform differential diagnosis but require further validation.
Clinical Best Practices
Conduct targeted metabolomics studies in independent cohorts. Replicate findings across diverse populations. Assess predictive performance of combined biomarker panels. Related Resources & Content
